カテゴリ： GlobalData, アメリカ, 企業調査

Xtant Medical Holdings Inc (XTNT)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Xtant Medical Holdings Inc (XTNT) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011558
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月22日
◆ページ数：63
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowrap, orbitalwrap HD, facet stabilization, milled cervical spacers, traditional allografts, hMatrix ADM, hMatrix PR ADM, and sports medicine. It utilizes sterile technology for manufacturing bacterin products. The company offers its products for the treatment of degenerative, traumatic, and deformity conditions for orthopedic and neurological applications. It operates in Louisiana, Maryland, Oregon, Illinois, Delaware, California, Florida, and New York. Xtant Medical is headquartered in Belgrade, Montana, the US.

Xtant Medical Holdings Inc (XTNT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Xtant Medical Holdings Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Xtant Medical Holdings Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Xtant Medical Holdings Inc, Medical Equipment, Deal Details 11
Partnerships 11
Xtant Medical Enters into Licensing Agreement with Sites Medical 11
X-spine Systems Enters into Licensing Agreement with Zimmer Spine 12
Xtant Medical Enters into Distribution Agreement with Curasan 13
Xtant Medical Enters into Distribution Agreement with Pinnacle Spine 14
Xtant Medical Enters into Distribution Agreement with Vivex Biomedical 15
Xtant Medical Enters into Agreement with Montana State University 16
Bacterin International Enters Into Distribution Agreement With Jeil Medical 17
Equity Offering 18
Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 18
Bacterin International Raises USD6.5 Million in Public Offering of Shares 20
Bacterin International Completes Private Placement Of Shares For US$4 Million 22
Xtant Medical Raises USD4.8 Million in Private Placement of Shares 23
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 24
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 25
Bacterin International Completes Private Placement Of Shares For US$3 Million 26
Bacterin International Completes Private Placement Of US$1 Million 27
Bacterin International Completes Private Placement Of US$1.9 Million 28
Debt Offering 29
Xtant Medical Raises USD65 Million in Private Placement of Notes 29
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 30
Acquisition 31
Bacterin International Acquires X-spine Systems 31
Bacterin International Completes Acquisition Of Robinson Medsurg 32
Xtant Medical Holdings Inc – Key Competitors 33
Xtant Medical Holdings Inc – Key Employees 34
Xtant Medical Holdings Inc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Strategy And Business Planning 36
Oct 06, 2017: Xtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility 36
Jul 26, 2016: Xtant Medical Announces the Operations Expansion of Montana’s Tissue Processing Rooms 37
Financial Announcements 38
Nov 21, 2017: Xtant Medical Reports Third Quarter 2017 Financial Results 38
Aug 09, 2017: Xtant Medical Reports Second Quarter 2017 Financial Results 40
May 09, 2017: Xtant Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period 41
Mar 09, 2017: Xtant Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period 42
Jan 11, 2017: XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA 44
Nov 07, 2016: Xtant Medical Holdings Reports Record Third Quarter 2016 Results 45
Oct 11, 2016: Xtant Medical Pre-Announces Record Third Quarter 2016 Revenue 46
Aug 01, 2016: Xtant Medical Reports Second Quarter 2016 Results 47
Jul 20, 2016: Xtant Medical Pre-Announces Second Quarter 2016 Revenue and EBITDA 48
May 04, 2016: Xtant Medical Reports First Quarter 2016 Results 49
Apr 19, 2016: Xtant Medical Pre-Announces First Quarter 2016 Revenue 50
Jan 12, 2016: Xtant Medical Holdings Reports Preliminary Fourth Quarter 2015 Financial Results 51
Corporate Communications 52
Feb 22, 2017: Xtant Medical Announces Appointment of Carl O’Connell to Permanent CEO 52
Jan 23, 2017: Xtant Medical CEO Dan Goldberger announces resignation 53
Oct 06, 2016: Xtant Medical Announces the Appointment of Carl O’Connell as President 54
Jun 16, 2016: Xtant Medical Announces Changes to Its Executive Management and Board of Directors 55
Legal and Regulatory 56
Nov 01, 2016: Xtant Medical Receives Approval of Compliance Plan from NYSE MKT 56
Aug 19, 2016: Xtant Medical Receives Non Compliance Notice from NYSE MKT 57
Product News 58
Oct 25, 2017: Xtant Medical to Feature Product Portfolio at the 2017 North American Spine Society Annual Meeting 58
May 26, 2016: Xtant Medical completes new accounts receivable revolver credit facility with Silicon Valley Bank 59
Other Significant Developments 60
Aug 16, 2016: Xtant Medical Expands AR Credit Facility with Silicon Valley Bank 60
May 26, 2016: Xtant Medical completes new accounts receivable revolver credit facility with Silicon Valley Bank 61
Apr 26, 2016: Xtant Medical Announces Montana Department of Commerce Grant Awards 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
Xtant Medical Holdings Inc, Medical Equipment, Key Facts, 2016 2
Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Xtant Medical Holdings Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Xtant Medical Holdings Inc, Deals By Market, 2011 to YTD 2017 9
Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Xtant Medical Enters into Licensing Agreement with Sites Medical 11
X-spine Systems Enters into Licensing Agreement with Zimmer Spine 12
Xtant Medical Enters into Distribution Agreement with Curasan 13
Xtant Medical Enters into Distribution Agreement with Pinnacle Spine 14
Xtant Medical Enters into Distribution Agreement with Vivex Biomedical 15
Xtant Medical Enters into Agreement with Montana State University 16
Bacterin International Enters Into Distribution Agreement With Jeil Medical 17
Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 18
Bacterin International Raises USD6.5 Million in Public Offering of Shares 20
Bacterin International Completes Private Placement Of Shares For US$4 Million 22
Xtant Medical Raises USD4.8 Million in Private Placement of Shares 23
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 24
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 25
Bacterin International Completes Private Placement Of Shares For US$3 Million 26
Bacterin International Completes Private Placement Of US$1 Million 27
Bacterin International Completes Private Placement Of US$1.9 Million 28
Xtant Medical Raises USD65 Million in Private Placement of Notes 29
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 30
Bacterin International Acquires X-spine Systems 31
Bacterin International Completes Acquisition Of Robinson Medsurg 32
Xtant Medical Holdings Inc, Key Competitors 33
Xtant Medical Holdings Inc, Key Employees 34
Xtant Medical Holdings Inc, Subsidiaries 35

★海外企業調査レポート[Xtant Medical Holdings Inc (XTNT)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Hertz Global Holdings Inc：企業のM&A・事業提携・投資動向
    Hertz Global Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hertz Global Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Nan Ya Plastics Corporation：企業の戦略・SWOT・財務分析
    Nan Ya Plastics Corporation - Strategy, SWOT and Corporate Finance Report Summary Nan Ya Plastics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Motiva Enterprises LLC：企業の戦略的SWOT分析
    Motiva Enterprises LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Avantium NV (AVTX)：企業の財務・戦略的SWOT分析
    Avantium NV (AVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Croma-Pharma GmbH-医療機器分野：企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • Stentys SA (STNT)：企業の財務・戦略的SWOT分析
    Summary Stentys SA (Stentys) is a medical device company that designs, develops and markets self-expanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company’s products include xposition S self-applying stent, mistent biodegradable sirolimus relea …
  • World Reach Limited (WRR)：企業の財務・戦略的SWOT分析
    World Reach Limited (WRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PolyPid Ltd-医療機器分野：企業M&A・提携分析
    Summary PolyPid Ltd (PolyPid) is a clinical stage pharmaceutical company that develops, manufactures and commercialize drugs for extended release and local delivery. The company develops its products using PLEX (Polymer-Lipid Encapsulation MatriX) platform, which helps in products. PolyPid’s pipelin …
  • Musgrave Group Plc：企業の戦略・SWOT・財務情報
    Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report Summary Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tieto Corp (TIETO)：企業の財務・戦略的SWOT分析
    Tieto Corp (TIETO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cogstate Ltd (CGS)-医療機器分野：企業M&A・提携分析
    Summary Cogstate Ltd (Cogstate) is a cognitive science company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. It also provides drug development strategies, protocol design, test selection for screening, s …
  • Ramco Cements Ltd：企業の戦略・SWOT・財務情報
    Ramco Cements Ltd - Strategy, SWOT and Corporate Finance Report Summary Ramco Cements Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Caixa Economica Montepio Geral：企業の戦略・SWOT・財務分析
    Caixa Economica Montepio Geral - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Montepio Geral - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Genesis Healthcare, Inc.：戦略・SWOT・企業財務分析
    Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sage Therapeutics Inc (SAGE)：企業の財務・戦略的SWOT分析
    Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Perpetual Energy Inc (PMT)：企業の財務・戦略的SWOT分析
    Perpetual Energy Inc (PMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Incanthera Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Incanthera Ltd (Incanthera) is a drug development and targeted cancer medicines company that discovers and develops novel treatments for solid tumours. The company's pipeline drug candidates include ICT01-2588, a vascular disrupting agent, based on the tumor-blasting technology; ICT03 – Es5, …
  • Borges International Group SLU：企業の戦略的SWOT分析
    Borges International Group SLU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • AIA Group Limited：企業の戦略・SWOT・財務情報
    AIA Group Limited - Strategy, SWOT and Corporate Finance Report Summary AIA Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • First Light Diagnostics Inc：企業の製品パイプライン分析
    Summary First Light Diagnostics Inc (FLD) is a medical device company that develops and manufactures automated medical diagnostic products for the detection of healthcare associated infections. The company’s product includes multipath analyzer system. Its multipath analyzer system detects resistant …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆